2007
DOI: 10.1016/j.resp.2006.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Helium–oxygen ventilation in the presence of expiratory flow-limitation: A model study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
16
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 34 publications
0
16
0
1
Order By: Relevance
“…It is located beyond the seventh (i.e. from the eighth onwards) generation during tidal breathing [2][3][4][5].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…It is located beyond the seventh (i.e. from the eighth onwards) generation during tidal breathing [2][3][4][5].…”
mentioning
confidence: 99%
“…Initially, the latter is histologically characterised by denuded epithelium, rupture of alveolar airway attachments, and increased number of polymorphonuclear leukocytes [6][7][8]. Studies in which heliox (80% He/20% O 2 ) was administered in COPD and chronic heart failure patients also provided corroborative evidence that EFLT was located in the peripheral airways [2][3][4][5]. EFLT promotes dynamic pulmonary hyperinflation and intrinsic positive end-expiratory pressure (PEEPi) with concurrent dyspnoea and exercise limitation [9].…”
mentioning
confidence: 99%
“…The resistive inspiratory work may also have been reduced [34,35]. In fact, the potential for helium to improve expiratory flow limitation increases with disease severity and with higher flow rates [34], i.e. the precise conditions found in the present study.…”
Section: Discussionmentioning
confidence: 50%
“…It is noteworthy that resting physiological variables were poorly predictive of changes in Tlim with HeHOx. Previous studies have suggested that any benefit from HeHOx would be particularly observed in patients with more central airflow limitation [13,34,35], which would allow them to maintain the same ventilation (or even higher, as in the present study) with a lower EELV. In practical terms, however, our data suggest that if HeHOX is to be used as an ergogenic aid in advanced COPD under LTOT its positive effects should be unequivocally demonstrated in individual patients.…”
Section: Discussionmentioning
confidence: 51%
See 1 more Smart Citation